Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes

American Journal of Transplantation

Volumn 2, Issue 3, 2002, Pages 274-281

  Hypolite, Iman O ^a   Bucci, Jay ^b,c   Hshieh, Paul ^c   Cruess, David ^c   Agodoa, Lawrence Y C ^a   Yuan, Christina M ^b,c   Taylor, Allen J ^b   Abbott, Kevin C ^b,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Acute coronary syndromes; Congestive heart failure; Diabetes mellitus; End stage renal disease; Hospitalization; Myocardial infarction; Renal transplant; Unstable angina; USRDS

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CAUSE OF DEATH; COMORBIDITY; CONFIDENCE INTERVAL; DEMOGRAPHY; DIABETES MELLITUS; DIALYSIS; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; UNITED STATES; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CONTINENTAL POPULATION GROUPS; CORONARY DISEASE; DATABASES, FACTUAL; DIABETIC RETINOPATHY; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; SYNDROME; TREATMENT FAILURE; WAITING LISTS;

EID: 0036523980     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20313.x     Document Type: Article

References (34)

1. Aakhus S, Dahl K, Widere TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Trans 1999; 14: 648-654.
2. USRDS 1999 Annual Data Report, NIH, NIDDKD. Cited in: Silkensen JR. Long-term complications in renal transplantation. J Am Soc Nephrol 2000; 11: 582-588.
3. USRDS 1999 Annual Data Report, NIH, NIDDKD. Cited in: Silkensen JR. Long-term complications in renal transplantation. J Am Soc Nephrol 2000; 11: 582-588.
4. Rao VK. Post-transplant medical complications. Surg Clin North Am 1998; 78: 113-132.
5. Herzog CA, Ma JZ, Collins AJ. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis 2000; 36: 145-152.
6. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant patients. Am J Med 1988; 84: 985-992.
7. Kasiske BL. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165.
8. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
9. Nakajima K, Ochiai T, Suzuki T et al. Beneficial effects of renal transplantation on cardiovascular disorders in dialysis patients. Surg Today 1998; 28: 811-815.
10. Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease. Trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol 2001; 12: 1293-1296.
11. http://www.usrds.org.
12. Kleinbaum DG. Survival Analysis: a Self-Learning Text. (Statistics in the Health Sciences). Seacaucus, New Jersey: Springer Verlag; 1996.
13. Maceneaney PM, Malone DE. Applying 'evidence-based medicine' theory to interventional radiology. Part 2: A spreadsheet for swift assessment of procedural benefit and harm. Clin Radiol 2000; 55: 938-945.
14. Theroux P, Ouimet H, McCans J et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988; 319: 1105-1111.
15. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.
16. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2. Lancet 1988; 2: 349-360.
17. Van de Werf F. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes. Thromb Haemost 1997; 78: 210-213.
18. Douzdjian V, Ferrara D, Silvestri G. Treatment strategies for insulin-dependent diabetics with ESRD. a cost-effectiveness decision analysis model. Am J Kidney Dis 1998; 31: 794-802.
19. Wilson PW, D'Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
20. Alvares S, Mota C, Soares L et al. Cardiac consequences of renal transplantation changes in left ventricular morphology. Rev Port Cardiol 1998; 17: 145-152.
21. Rigatto C, Foley RN, Kent GM, Guttman R, Parfrey PS. Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 2000; 70: 570-575.
22. McFalls EO, Archer SL. Rapid progression of aortic stenosis and secondary hyperparathyroidism. Am Heart J 1990; 120: 206-208.
23. Niederle B, Stefenelli T, Glogar D et al. Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study. Surgery 1990; 108: 1052-1056.
24. Mazzaferro S, Coen G, Bandini S et al. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant 1993; 8: 335-340.
25. Stefenelli T, Abela C, Frank H et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 1997; 82: 106-112.
26. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021.
27. Torres A, Rodriguez AP, Concepcion MT et al. Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. Nephrol Dial Transplant 1998; 13 (Suppl. 3): 94-97.
28. Ambuhl PM, Meier D, Wolf B et al. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis. Am J Kidney Dis 1999; 34: 875-883.
29. Dennis VW, Robinson K. Homocysteinemia and vascular disease in end-stage renal disease. Kidney Int 1996; 57 Suppl: S11-S17.
30. Van Guldener C, Janssen MJ, Stehouwer CD et al. The effect of renal transplantation on hyperhomocysteinemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function. Neth J Med 1998; 52: 58-64.
31. Bostom AG, Shemin D, Gohh RY et al. Lower fasting total plasma homocysteine levels in stable renal transplant recipients versus maintenance dialysis patients. Transplant Proc 1998; 30: 160-162.
32. Dimeny E, Hultberg B, Wahlberg J et al. Serum total homocysteine concentration does not predict outcome in renal transplant recipients. Clin Transplant 1998; 12: 563-568.
33. Assaf AR, Lapane KL, McKenney JL, Carleton RA. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. N Engl J Med 1993; 329: 931-935.
34. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989; 320: 904-910.